Centro Integral en Reumatologia SA de CV
Guadalajara, Jalisco, Mexico
Doctor in Guadalajara
Av. de la Paz 1919, Col Americana, Americana, 44160 Guadalajara, Jal.
About Centro Integral en Reumatologia SA de CV
"En el Centro Integral de Reumatología, S.A. de C.V. (CIRSA), realizamos actividades de Investigación Clínica con especialidad en Enfermedades Reumatológicas. Contamos con más de 20 años de experiencia en la realización de ensayos clínicos, aportando a nuestros pacientes bienestar, satisfacción y confianza."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Eli Lilly and Company
3
Hoffmann-La Roche
3
Amgen
2
Bristol-Myers Squibb
2
Celgene
1
Horizon Therapeutics Ireland DAC
1
Idorsia Pharmaceuticals Ltd.
1
Iltoo Pharma
1
Janssen Research & Development, LLC
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Centro Integral en Reumatologia SA de CV
During the past decade, Centro Integral en Reumatologia SA de CV conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 13 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
2013-10-01
2015-06-01
Terminated
180
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
2014-01-20
2015-12-18
Completed
422
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
2013-08-01
2016-04-01
Completed
395
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
2014-02-17
2019-05-20
Completed
686
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro Integral en Reumatologia SA de CV" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bristol-Myers Squibb"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integral en Reumatologia SA de CV"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centro Integral en Reumatologia SA de CV
According to Clinical.Site data, the most researched conditions in "Centro Integral en Reumatologia SA de CV" are
"Systemic Lupus Erythematosus" (6 trials), "Rheumatoid Arthritis" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Psoriatic Arthritis" (2 trials). Many other conditions were trialed in "Centro Integral en Reumatologia SA de CV" in a lesser frequency.
Clinical Trials Intervention Types at Centro Integral en Reumatologia SA de CV
Most popular intervention types in "Centro Integral en Reumatologia SA de CV" are "Drug" (22 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Baricitinib" (3 trials), "Adalimumab" (2 trials), "Etrolizumab" (2 trials) and "Methotrexate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Integral en Reumatologia SA de CV
The vast majority of trials in "Centro Integral en Reumatologia SA de CV" are
23 trials for "All" genders.
Clinical Trials Status at Centro Integral en Reumatologia SA de CV
Currently, there are NaN active trials in "Centro Integral en Reumatologia SA de CV".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 12 completed trials in Centro Integral en Reumatologia SA de CV,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Integral en Reumatologia SA de CV, 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".